WAG
GILD icon

Wilkerson Advisory Group’s Gilead Sciences GILD Stock Holding History

Wilkerson Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.3K Sell
200
-22
-10% -$2.9K 0.01% 301
2026
Q1 		$30.9K Buy
222
+78
+54% +$10.9K 0.01% 252
2025
Q4 		$17.7K Buy
+144
New +$17.5K 0.01% 256

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wilkerson Advisory Group's GILD Position: Q2 2026 in Review

Wilkerson Advisory Group reduced its Gilead Sciences (GILD) stake by 9.9% in Q2 2026, selling an estimated $2.9K and leaving 200 shares worth $25.3K. The position accounts for 0.01% of the portfolio, ranked #301.

Wilkerson Advisory Group first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $30.9K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wilkerson Advisory Group held 200 shares of Gilead Sciences worth $25.3K as of Q2 2026.
  • Wilkerson Advisory Group sold 22 Gilead Sciences shares in Q2 2026, an estimated $2.9K.
  • Gilead Sciences made up 0.01% of Wilkerson Advisory Group's portfolio in Q2 2026, its #301 holding.
  • Wilkerson Advisory Group first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Wilkerson Advisory Group's Gilead Sciences position peaked at $30.9K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wilkerson Advisory Group's 13F filing for Q2 2026, filed 21 Jul 2026.